Gene E Floyd Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 219 N Mine St, Mc Cormick, SC 29835 Phone: 864-852-3336 Fax: 864-852-3339 |
Lisa D Jennings, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 219a N Mine St, Mc Cormick, SC 29835 Phone: 864-852-3336 Fax: 864-852-3339 |
Dr. John Browning Mcree, MD Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: S Carolina Dept Of Corrections, Redemption Way, Mc Cormick, SC 29899 Phone: 803-734-0330 Fax: 864-443-2121 |
Dr. Ashley C Wiggins, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 219a N Mine St, Mc Cormick, SC 29835 Phone: 864-852-3336 Fax: 864-852-3339 |
Dan W Robinson Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 131 Holiday Rd, Mc Cormick, SC 29835 Phone: 864-391-2025 Fax: 864-391-2030 |
Gregory T Lang, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 207 Holiday Rd, Mc Cormick, SC 29835 Phone: 864-391-5011 Fax: 864-391-5012 |
News Archive
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice. The results reinforce previous findings that antioxidants hasten the progression of lung cancer. According to Professor Martin Bergö, people with cancer or an elevated risk of developing the disease should avoid nutritional supplements that contain antioxidants.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
Getting discharged from the hospital and then having to go right back in again can be emotionally draining for a patient and their family. It can also cause financial strain for all involved - the patient, the hospital system and the insurers-including Medicaid and Medicare, which are taxpayer funded.
U.N. Secretary-General Ban Ki-moon has urged more funding for the GAVI Alliance to help achieve its childhood vaccine targets and the related Millennium Development Goals (MDGs), TopNews reports.
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.
› Verified 8 days ago